FDA applicant
Kci USA, Inc.
FDA records 28 decisions for Kci USA, Inc. (San Antonio, TX) from 2006 to 2024: 27 510(k) clearances and 1 De Novo grant. Most are in product codes OMP (Negative Pressure Wound Therapy Powered…) and QFC (Negative Pressure Wound Therapy Device For…). Since 2016 its 510(k)s took a median of 118 days from receipt to decision, against 214 for FDA’s reviews in the same codes and years. Its devices cite 35 predicates, 19 of them its own earlier devices. 14 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Kci USA, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
1in 2020
Class I Class II/III not classified
Planning a device like Kci USA, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report